pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

NIH awards all grant money but delays and opaque decisions hinder researchers, cuts health disparity funding

Oct 2, 2026·read at STAT ↗RegulatoryNegative

The National Institutes of Health announced that it has allocated the full amount of its grant budget for fiscal year 2026, but the timing and transparency of award decisions have been problematic for investigators.

Researchers report that the slow, unclear process is slowing projects and creating uncertainty about funding continuity.

At the same time, the agency continued to trim grants that focus on health disparities, race and ethnicity, a trend that has drawn criticism from the scientific community.

Despite the budget being fully funded, the NIH made little headway on other administration‑driven priorities, leaving many stakeholders concerned about the overall impact on public‑health research.

source

This writeup was produced by pharmadog from original reporting by STAT. The original article may no longer be reachable at its published URL.

Original headline: “STAT+: NIH awarded all its grant funding, but delayed and opaque decisions stymied researchers”

read at STAT ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
National Institutes of Health

related stories

  • Jun 5STAT+: What stripping civil service protections for thousands of federal workers will mean for HHSSTAT
  • Jun 5Tiny HHS office tasked with protecting research participants’ safety is running on fumesSTAT
  • Jun 4STAT+: RFK Jr.’s second year: Vacancies, not vaccinesSTAT
  • Jun 4Scientists uncover a new hiding spot for HIVSTAT
  • Jun 4STAT+: Trump administration to strip job protections of top NIH officials, grants staffSTAT